Detection of acute atrial thrombus in a porcine model with atrial fibrillation with tc 99m-apcitide

Invest Radiol. 2004 Apr;39(4):197-201. doi: 10.1097/01.rli.0000112901.01665.e1.

Abstract

Rationale and objectives: Technetium-99m apcitide (AcuTect) is a peptide with high affinity and specificity for glycoprotein IIb/IIIa receptors on platelets and is currently approved for the diagnosis of deep venous thrombosis. This study evaluates the use of Tc-99m apcitide for detecting intracardiac thrombus in an animal model with atrial fibrillation.

Methods: Thrombogenic material (0.23+/- 0.03 g) was implanted within the left atrium of 5 swine with induced atrial fibrillation. Scintigraphy was performed with a small field of view gamma camera (minimum of 400000 counts) 1 hour after implantation at 10, 60, and 120 minutes after the injection of the Tc-99m apcitide. Animals were then euthanized and a postmortem examination performed to confirm thrombus formation.

Results: : In all animals, thrombi and microthrombi were confirmed within the left atrial appendage. The average wet weight of the thrombus was 1.4 +/- 0.2 g. Tc-99m apcitide detected left atrial thrombus in all animals.

Conclusions: This study suggests that AcuTect may prove useful for detecting intracardiac thrombus in future clinical studies in man.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Acute Disease
  • Animals
  • Atrial Fibrillation / complications*
  • Female
  • Heart Atria / diagnostic imaging
  • Heart Diseases / diagnostic imaging*
  • Organotechnetium Compounds*
  • Peptides, Cyclic*
  • Radionuclide Imaging
  • Radiopharmaceuticals*
  • Swine
  • Thrombosis / diagnostic imaging*
  • Thrombosis / etiology

Substances

  • Organotechnetium Compounds
  • Peptides, Cyclic
  • Radiopharmaceuticals
  • technetium Tc 99m P280